Squamous cell carcinoma of the rectum

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:424002C20
Who is this for?
Show terms as
1FDA treatments1Active trials37Specialists8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Squamous cell carcinoma of the rectum (also called rectal squamous cell carcinoma or SCC of the rectum) is a very rare type of cancer that starts in the rectum — the last section of the large intestine, just before the anus. Unlike the much more common rectal adenocarcinoma, which grows from gland cells, this cancer grows from flat, scale-like cells called squamous cells. These cells are not normally found in the rectum in large numbers, which is part of why this cancer is so unusual. The cancer can cause symptoms similar to other rectal cancers, including rectal bleeding, changes in bowel habits, pain or pressure in the lower abdomen or rectum, and a feeling that the bowel does not fully empty. Because it is so rare, it is often mistaken for more common rectal cancers or for anal squamous cell carcinoma, which can delay diagnosis. Treatment usually involves a combination of radiation therapy and chemotherapy (called chemoradiation), sometimes followed by surgery to remove the tumor. The approach is often borrowed from treatment strategies used for anal squamous cell carcinoma, since both share the same cell type. Early detection gives the best chance of successful treatment, but because this cancer is so rare, there are no large clinical trials specifically designed for it, and treatment decisions are often made on a case-by-case basis.

Also known as:

Key symptoms:

Rectal bleeding or blood in the stoolChanges in bowel habits, such as diarrhea or constipationFeeling that the bowel does not fully empty after a bowel movementPain or pressure in the lower abdomen or rectumNarrow or pencil-thin stoolsUnexplained weight lossFatigue or tiredness without a clear causeA lump or mass that can be felt in or near the rectumMucus in the stoolAnal or rectal pain, especially during bowel movements

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Aug 2024High Resolution Anuscopy Study

Universitair Ziekenhuis Brussel

TrialRECRUITING
Apr 2024Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma

Sixth Affiliated Hospital, Sun Yat-sen University — PHASE2

TrialRECRUITING
Sep 2023MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

University Health Network, Toronto — PHASE2

TrialRECRUITING
Sep 2023Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

National Cancer Institute, Naples

TrialRECRUITING
Jun 2023A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

Latin American Cooperative Oncology Group

TrialRECRUITING
May 2023Adaptive Radiation in Anal Cancer

Columbia University — NA

TrialRECRUITING
Jun 2022Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma

Centre Hospitalier Universitaire de Besancon — PHASE2

TrialRECRUITING
Jan 2022Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.

Centre Hospitalier Universitaire de Besancon — PHASE2

TrialACTIVE NOT RECRUITING
Apr 2021Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma

Umeå University — NA

TrialRECRUITING
Nov 2020A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

Brigham and Women's Hospital — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Bavencio

avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1)· EMD Serono Research and Development Institute, Inc.
BAVENCIO is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who have disease progression during or following platinum-containing chemotherapy or h

BAVENCIO is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
Phase 2
Actively Recruiting
PI: Jun Huang, MD (Sixth Affiliated Hospital, Sun Yat-sen University) · Sites: Guangzhou, Guangdong · Age: 1875 yrs

Specialists

Showing 25 of 37View all specialists →
GP
Gooitzen van Dam, MD, PhD
Specialist
PI on 2 active trials
RM
Ryan W Huey, MD
HOUSTON, TX
Specialist
PI on 1 active trial
NM
Nikita Malakhov
NEW YORK, NY
Specialist
1 Squamous cell carcinoma of the rectum publication
ST
Shinji Tsutsumi
Specialist
1 Squamous cell carcinoma of the rectum publication
AL
Anna Lee
Specialist
1 Squamous cell carcinoma of the rectum publication
JK
Joseph K Kim
Specialist
1 Squamous cell carcinoma of the rectum publication
YZ
Yanyang Zhou
Specialist
1 Squamous cell carcinoma of the rectum publication
DB
Dinesh K Badakh
Specialist
1 Squamous cell carcinoma of the rectum publication
UP
Uday Arun Phatak
PROSPECT HEIGHTS, IL
Specialist
1 Squamous cell carcinoma of the rectum publication
CM
Christian S Hinrichs, MD
BETHESDA, MD
Specialist
PI on 2 active trials
CE
Cathy Eng
Specialist
PI on 3 active trials53 Squamous cell carcinoma of the rectum publications
RK
Rafi Kabarriti
BRONX, NY
Specialist
PI on 1 active trial
DM
Dawn Pinchasik, MD
PITTSBURGH, PA
Specialist
PI on 2 active trials
AM
Antonius Miller
Specialist
PI on 2 active trials79 Squamous cell carcinoma of the rectum publications
JP
Jason Koutcher, MD, PhD
NEW YORK, NY
Specialist
PI on 2 active trials
SM
Scot C. Remick, MD
SCARBOROUGH, ME
Specialist
PI on 9 active trials
AM
Alain Mita
NEWPORT BEACH, CA
Specialist
PI on 1 active trial1 Squamous cell carcinoma of the rectum publication
PA
Paul Adedoyin
HUNTINGTON, WV
Specialist
1 Squamous cell carcinoma of the rectum publication
SS
Shigeru Shibata
Specialist
1 Squamous cell carcinoma of the rectum publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

2 resources
Bavencio(avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1))EMD Serono Research and Development Institute, Inc.

OPDIVO

E.R. Squibb & Sons, L.L.C.

OPDIVO — Contact E.R. Squibb & Sons, L.L.C.

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Squamous cell carcinoma of the rectum.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Squamous cell carcinoma of the rectumForum →

No community posts yet. Be the first to share your experience with Squamous cell carcinoma of the rectum.

Start the conversation →

Latest news about Squamous cell carcinoma of the rectum

Disease timeline:

New recruiting trial: Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: Adaptive Radiation in Anal Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: High Resolution Anuscopy Study

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

New recruiting trial: Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

A new clinical trial is recruiting patients for Squamous cell carcinoma of the rectum

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my cancer, and has it spread beyond the rectum?,Should my tumor be tested for HPV or other markers that might affect my treatment?,Is chemoradiation the right first step for me, or should surgery be considered?,Are there any clinical trials I might be eligible for given how rare this cancer is?,What are the chances that treatment will result in complete remission?,Should I be referred to a major cancer center that specializes in rare gastrointestinal cancers?,What long-term side effects should I expect from treatment, and how can they be managed?

Common questions about Squamous cell carcinoma of the rectum

What is Squamous cell carcinoma of the rectum?

Squamous cell carcinoma of the rectum (also called rectal squamous cell carcinoma or SCC of the rectum) is a very rare type of cancer that starts in the rectum — the last section of the large intestine, just before the anus. Unlike the much more common rectal adenocarcinoma, which grows from gland cells, this cancer grows from flat, scale-like cells called squamous cells. These cells are not normally found in the rectum in large numbers, which is part of why this cancer is so unusual. The cancer can cause symptoms similar to other rectal cancers, including rectal bleeding, changes in bowel ha

How is Squamous cell carcinoma of the rectum inherited?

Squamous cell carcinoma of the rectum follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Squamous cell carcinoma of the rectum typically begin?

Typical onset of Squamous cell carcinoma of the rectum is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Squamous cell carcinoma of the rectum?

Yes — 1 recruiting clinical trial is currently listed for Squamous cell carcinoma of the rectum on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Squamous cell carcinoma of the rectum?

25 specialists and care centers treating Squamous cell carcinoma of the rectum are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Squamous cell carcinoma of the rectum?

2 patient support programs are currently tracked on UniteRare for Squamous cell carcinoma of the rectum. See the treatments and support programs sections for copay assistance, eligibility, and contact details.